McCulloch Kevin

McCulloch Kevin is listed in filings as See Remarks at Xeris Biopharma Holdings, Inc.. This profile follows SEC Form 4 activity through Mar 16, 2026, including sale activity and purchase activity. Recent filings connect the profile to Xeris Biopharma Holdings, Inc. (XERS). The current snapshot covers public activity from Aug 2, 2024 to Mar 16, 2026. Reported amounts are shown as $200.0K to $503.8K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.